Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 May 8;22(7):1275–1283. doi: 10.1016/j.bbmt.2016.04.004

Figure 2.

Figure 2

(A) CMV infection-free survival over time in a cohort of 91 SCT recipients at risk for CMV infection, starting from the day of stem cell infusion. (B) CMV infection-free survival over time in a cohort of 91 SCT recipients at risk for CMV infection, starting from day of stem cell infusion, by SCT recipient CMV serostatus (P = .002). (C) Treatment-related morality–free survival, starting from day of stem cell infusion, by SCT recipient CMV serostatus (P = .01).